Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · IEX Real-Time Price · USD
14.66
+0.07 (0.48%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Bausch + Lomb Revenue
Bausch + Lomb had revenue of $4.31B in the twelve months ending March 31, 2024, with 13.23% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.10B with 18.05% year-over-year growth. In the year 2023, Bausch + Lomb had annual revenue of $4.15B with 10.03% growth.
Revenue (ttm)
$4.31B
Revenue Growth
+13.23%
P/S Ratio
1.19
Revenue / Employee
$324,361
Employees
13,300
Market Cap
5.15B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.15B | 378.00M | 10.03% |
Dec 31, 2022 | 3.77B | 3.00M | 0.08% |
Dec 31, 2021 | 3.77B | 353.00M | 10.35% |
Dec 31, 2020 | 3.41B | -366.00M | -9.69% |
Dec 31, 2019 | 3.78B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grifols | 7.32B |
Organon & Co. | 6.35B |
DENTSPLY SIRONA | 3.94B |
Lantheus Holdings | 1.37B |
Merit Medical Systems | 1.28B |
Stevanato Group | 1.18B |
Doximity | 475.42M |
Krystal Biotech | 95.95M |
BLCO News
- 15 days ago - Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress - Business Wire
- 22 days ago - Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States - Business Wire
- 4 weeks ago - Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States - Business Wire
- 4 weeks ago - Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results - Business Wire
- 5 weeks ago - Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry's Meeting® - Business Wire
- 5 weeks ago - Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens - Business Wire
- 2 months ago - Bausch + Lomb Announces First-Quarter 2024 Results - Business Wire
- 2 months ago - Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting - Business Wire